Journal article
Intra-arterial versus intravenous abciximab therapy for thromboembolic complications of neuroendovascular procedures: case review and meta-analysis
Journal of neurointerventional surgery, Vol.9(2), pp.131-136
02/2017
DOI: 10.1136/neurintsurg-2016-012587
PMID: 27540089
Abstract
BackgroundAbciximab is used to treat thromboembolic complications of neuroendovascular procedures, but outcomes of treatment are not well defined.ObjectiveTo examine the angiographic and clinical outcomes based on route of abciximab administration and degree of vessel recanalization.Materials and methodsA prospectively maintained database of neuroendovascular procedures performed between January 2004 and May 2015 was retrospectively reviewed to identify cases with thromboembolic complications treated with abciximab. In these cases, route of administration, degree of vessel recanalization, and presence or absence of infarction were determined. A meta-analysis of similar cases in the literature was also performed.ResultsAbciximab was administered in 0.24% (47 of 19 566) of procedures to treat thromboemboli in 59 vessels. Angiographic improvement was seen in 94% after IA therapy and 79% after IV therapy (p=0.133). In our meta-analysis of 391 treated patients, angiographic improvement was greater after IA (91.7%) than IV (77.4%) treatment (p<0.001). Postprocedural infarction occurred more frequently with distal lesions (42%) than local lesions (12%) (p=0.014), and occlusive lesions (36%) than non-occlusive lesions (4.8%) (p=0.010). Infarction was significantly less common with complete angiographic resolution (0%) than with partial or no improvement (54%) (p<0.001). Symptomatic intracranial hemorrhage occurred in 2.1%.ConclusionsAbciximab produces a high rate of angiographic improvement and a low incidence of postprocedural infarct in neuroendovascular procedures complicated by thromboemboli. IA abciximab produces greater angiographic improvement than IV treatment. Postprocedural infarction is less common in patients with complete angiographic response than in those with partial or no response.
Details
- Title: Subtitle
- Intra-arterial versus intravenous abciximab therapy for thromboembolic complications of neuroendovascular procedures: case review and meta-analysis
- Creators
- Akash P Kansagra - Mallinckrodt Institute of Radiology, Washington University School of Medicine, Saint Louis, Missouri, USAJames D McEachern - Mallinckrodt Institute of Radiology, Washington University School of Medicine, Saint Louis, Missouri, USAThomas P Madaelil - Mallinckrodt Institute of Radiology, Washington University School of Medicine, Saint Louis, Missouri, USAAdam N Wallace - Mallinckrodt Institute of Radiology, Washington University School of Medicine, Saint Louis, Missouri, USADeWitte T Cross - Department of Neurosurgery, Washington University School of Medicine, Saint Louis, Missouri, USAChristopher J Moran - Department of Neurosurgery, Washington University School of Medicine, Saint Louis, Missouri, USAColin P Derdeyn - Department of Radiology, University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA
- Resource Type
- Journal article
- Publication Details
- Journal of neurointerventional surgery, Vol.9(2), pp.131-136
- DOI
- 10.1136/neurintsurg-2016-012587
- PMID
- 27540089
- ISSN
- 1759-8478
- eISSN
- 1759-8486
- Language
- English
- Date published
- 02/2017
- Academic Unit
- Neurology; Radiology; Iowa Neuroscience Institute; Neurosurgery
- Record Identifier
- 9984013919002771
Metrics
10 Record Views